Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

High Insulin Linked To Irregular Periods

WEDNESDAY, June 4, 2025 Elevated insulin levels could be causing irregular menstrual bleeding in women, a new study says.Women with excess levels of insulin are

Coffee Could Be Key To Aging Gracefully

WEDNESDAY, June 4, 2025 A morning cup of coffee might do more than momentarily boost your energy and spirits.Full-test java also appears to help women age more

Pepto Bismol May Not Prevent Traveler’s Diarrhea, New Study Finds

WEDNESDAY, June 4, 2025 Pepto Bismol is a go-to stomach remedy, but a new study suggests it might not help prevent diarrhea during international travel.The stud

Judge Says Transgender Inmates Must Have Access to Hormone Therapy

WEDNESDAY, June 4, 2025 A federal judge has ruled that transgender inmates in U.S. prisons must continue getting medical care, including hormone therapy and gen

Moderna's New Lower-Dose COVID-19 Vaccine Approved by FDA

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome

Autism Spectrum Disorder Linked to Increased Risk for Parkinson Disease

Autism spectrum disorder (ASD) is associated with an increased risk for Parkinson disease (PD), according to a study published online May 27 in JAMA Neurology.W

Acupuncture May Alleviate Nocturia in Men Treated for Prostate Cancer

Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online May 29 in JAMA Oncology.Kevin T. Liou,

Early Results from Johnson & Johnson’s Trispecific Antibody JNJ-5322 Show Promising Response in Heavily Pretreated Multiple Myeloma Patients

Chicago (June 3, 2025) Johnson Johnson announced today initial Phase 1 results of JNJ-79635322 (JNJ-5322), a novel investigational trispecific antibody (TsAb) i

Rilzabrutinib Granted Orphan Drug Designation in the US for Sickle Cell Disease

Paris, June 3, 2025. The US Food and Drug Administration (FDA) has granted orphan drug designation to rilzabrutinib, a novel, advanced, oral, reversible Bruton

Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis

Amylyx Pharmaceuticals, Inc. (NASDAQ AMLX) ( Amylyx or the Company ) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track des

Popular Keywords